Gregory Norden
Chief Financial Officer, WYETH.
Companies
- Praxis Precision Medicines, Inc.Board member Oct 15, 2020 to now1
- Royalty Pharma plcBoard member Jun 15, 2020 to now2
- ZoetisBoard member Jan 31, 2013 to now3
- NanoString TechnologiesBoard member Jun 25, 2013 to May 8, 20244
- Entasis TherapeuticsBoard member Sep 25, 2018 to Jun 21, 20195
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Royalty Pharma plc RPRX196,348 shares6$11.9M at $60.48Jun 5, 2026
Zoetis ZTS5,548 shares7$439.9K at $79.28Mar 10, 2026- Praxis Precision Medicines, Inc. PRAX1,559 shares8$404.6K at $259.50Jun 10, 2026
NanoString Technologies88,552 shares9May 6, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 10, 2026Granted 1,371 shares of Praxis Precision Medicines, Inc.8
- Jun 5, 2026Granted 4,545 shares of Royalty Pharma plc6
- May 14, 2026Sold 3,045 shares at $53.00 of Royalty Pharma plc10
- Mar 9, 2026Gift 1,213 shares of Zoetis7
- Feb 19, 2026Other 406 shares at $127.28 of Zoetis11
- Feb 19, 2026Exercised options 1,619 shares of Zoetis11
- Aug 11, 2025Sold 33,500 shares at $36.23 of Royalty Pharma plc12
- Aug 8, 2025Converted 144,660 shares of Royalty Pharma plc12
- May 13, 2025Granted 7,614 shares of Royalty Pharma plc13
- Feb 14, 2025Gift 1,843 shares of Zoetis14
- Feb 8, 2025Other 308 shares at $171.43 of Zoetis15
- Feb 8, 2025Exercised options 1,225 shares of Zoetis15
- Feb 6, 2025Other 310 shares at $174.12 of Zoetis16
- Feb 6, 2025Exercised options 1,236 shares of Zoetis16
- Jun 7, 2024Granted 9,293 shares of Royalty Pharma plc17
- May 6, 2024Exercised options 41,133 shares of NanoString Technologies9
- Feb 21, 2024Gift 2,214 shares of Zoetis18
- Feb 10, 2024Other 367 shares at $197.32 of Zoetis19
- Feb 10, 2024Exercised options 1,463 shares of Zoetis19
- Feb 8, 2024Other 375 shares at $195.75 of Zoetis20
- Feb 8, 2024Exercised options 1,493 shares of Zoetis20
- Jun 23, 2023Granted 7,747 shares of Royalty Pharma plc21
- Jun 17, 2023Exercised options 14,851 shares of NanoString Technologies22
- May 19, 2023Gift 2,659 shares of Zoetis23
- May 15, 2023Gift 2,659 shares of Zoetis23
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARRoyalty Pharma plc, Board member
- 3SEC EDGARZoetis, Board member
- 4
- 5SEC EDGAREntasis Therapeutics, Board member
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed May 15, 2026
- 11SEC EDGARForm 4 filed Feb 23, 2026
- 12SEC EDGARForm 4 filed Aug 11, 2025
- 13SEC EDGARForm 4 filed May 14, 2025
- 14SEC EDGARForm 4 filed Feb 18, 2025
- 15SEC EDGARForm 4 filed Feb 11, 2025
- 16SEC EDGARForm 4 filed Feb 10, 2025
- 17SEC EDGARForm 4 filed Jun 10, 2024
- 18SEC EDGARForm 4 filed Feb 22, 2024
- 19SEC EDGARForm 4 filed Feb 13, 2024
- 20SEC EDGARForm 4 filed Feb 12, 2024
- 21SEC EDGARForm 4 filed Jun 26, 2023
- 22SEC EDGARForm 4 filed Jun 20, 2023
- 23SEC EDGARForm 4 filed May 22, 2023